跳至主要内容
临床试验/JPRN-UMIN000036098
JPRN-UMIN000036098暂停未知

The effect of lowering blood glucose regarding SGLT2 inhibitor in type 1 diabetes mellitus - The effect of SGLT2 inhibitor in type 1 diabetes mellitus

Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital0 个研究点目标入组 20 人开始时间: 2019年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who treat with CSII. 2.Patients who have history of diabetic coma, severe diabetic ketosis or hyperglycemic hyperosmolar symdrome. 3.1.Patients with severe infection, severe injury or perioperative state. 4.1.Patients with severe diabetic complications such as neuropathy, retinopathy and nephropathy. 5.BMI of patients under 17.5 kg/m2. 6.eGFR of patients less than 45 mL/min/1.73m2. 7.Patients with history of ileus. 8.Patients with vulvitis. 9.Pregnant 10.Patients whom researchers rule out as inappropriate subjects.

研究者

发起方
Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital

相似试验